Chief Financial Officer

Chief Commercial Officer

ARS Pharmaceuticals, Inc. (SPRY): A Bull Case Theory

Roth starts ARS Pharmaceuticals at Buy, sees 'vast improvement' from Neffy

Anaphylaxis Market to Reach USD 3.9 Bn by 2035, Expanding at a CAGR of 5.9% | Transparency Market Research, Inc.

ARS Pharmaceuticals initiated with bullish view at Roth Capital

Specialty Sales Representative

ARS Pharmaceuticals is a fast growing and innovative company committed to improving patient outcomes with novel products. The Specialty Sales Representative will be responsible for driving brand recognition and adoption, engaging with healthcare providers and stakeholders, and developing business relationships to contribute to the success of the product launch.

Sign up with Google

Sign in with Google